Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

24 Nov 2020 07:00

RNS Number : 2423G
Devro PLC
24 November 2020
 

24 November 2020

Devro plc

 

Trading Update

 

Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 1 July to 31 October 2020 (the "period").

Trading Update and Outlook

Trading in the period remained robust, despite the impact of COVID-19 on the food service channel, with collagen volumes growing and Group operating margins improving. As a result, our expectations for the full year remain unchanged.

Emerging markets continued to grow well in the period. Most mature markets grew, but this was more than offset by declines in Continental Europe and UK & Ireland mainly reflecting a weaker food service channel. For the full year we still expect good growth in emerging markets to offset a decline in our mature markets leading to broadly flat collagen volumes, with an estimated 2% net negative impact from COVID-19.

The Bellshill site closure and transfer of production lines to the Czech site remain on track.

On the 13 November 2020 Group net debt was £123.8m. In line with our normal seasonal cash generation we expect net debt to improve by year-end, to a similar level as of 30 June 2020, with the covenant net debt / underlying EBITDA ratio less than 2x. We expect strong cash generation in 2021 to drive leverage down further.

The interim dividend, announced in July, of 2.7p will be paid to shareholders on 15 January 2021. As previously announced the postponed 2019 final dividend of 6.3p, was paid in the form of a second interim dividend in October 2020.

Rutger Helbing, Chief Executive, said:

"We continued to make good underlying progress in the period. While we expect market conditions to remain challenging for the rest of the year we remain on track to deliver against our expectations. This is testament to the contribution of our people and I would again like to put on the record my gratitude for all their hard work. All sites remain open and we continue to provide good service to our customers and fulfil our role in the food supply chain."

ENDS 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Jackie Callaway

Chief Financial Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain

Nick Hasell

Tel: 020 3727 1340

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLTLTLVFII
Date   Source Headline
9th Dec 202211:54 amRNSForm 8.5 (EPT/RI) - Devro PLC
9th Dec 202210:52 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - DEVRO PLC - Ordinary Shares
9th Dec 202210:41 amRNSForm 8.5 (EPT/RI) - Devro plc
8th Dec 20226:13 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
8th Dec 20226:12 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
8th Dec 20223:00 pmBUSForm 8.3 - Devro plc
8th Dec 20222:49 pmRNSForm 8.3 - DEVRO PLC
8th Dec 20222:49 pmRNSForm 8.3 - Devro plc
8th Dec 20222:37 pmRNSForm 8.3 - Devro Plc
8th Dec 202212:59 pmGNWForm 8.3 - [Devro plc - 07 12 2022] - (CGWL)
8th Dec 202212:16 pmBUSForm 8.3 - Devro plc
8th Dec 202211:17 amRNSForm 8.5 (EPT/RI) - Devro PLC
8th Dec 202211:02 amRNSForm 8.5 (EPT/RI)-Devro plc
7th Dec 20223:00 pmBUSForm 8.3 - DVO LN
7th Dec 20222:48 pmRNSForm 8.3 - Devro plc
7th Dec 20222:36 pmRNSForm 8.3 - Devro plc
7th Dec 20221:50 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
7th Dec 202212:52 pmGNWForm 8.3 - [Devro plc - 06 12 2022] - (CGWL)
7th Dec 202211:23 amRNSForm 8.3 - Devro Plc
7th Dec 202211:16 amRNSForm 8.3 - Devro plc
7th Dec 202211:08 amRNSForm 8.5 (EPT/RI)-Devro plc
7th Dec 202210:42 amRNSForm 8.3 - Devro Plc
6th Dec 20222:45 pmRNSForm 8.3 - Devro plc
6th Dec 20221:43 pmBUSForm 8.3 - Devro plc
6th Dec 20221:39 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
6th Dec 20221:30 pmBUSForm 8.3 - DEVRO PLC
6th Dec 202212:52 pmRNSForm 8.3 - Devro plc / Saria Nederland B.V.
6th Dec 202211:42 amRNSForm 8.3 - Devro PLC
6th Dec 202211:37 amGNWForm 8.3 - [Devro plc - 05 12 2022] - (CGWL)
6th Dec 202211:14 amRNSForm 8.5 (EPT/NON-RI) - Devro plc
6th Dec 202211:09 amRNSForm 8.5 (EPT/RI) - Devro plc
6th Dec 202211:07 amBUSForm 8.3 - Devro plc
6th Dec 202211:00 amRNSForm 8.3 - Devro PLC
6th Dec 202210:16 amRNSForm 8.3 - Devro Plc
6th Dec 202210:09 amRNSForm 8.5 (EPT/RI) - Devro PLC
5th Dec 20223:00 pmBUSForm 8.3 - DVO LN
5th Dec 20222:04 pmRNSForm 8.3 - Devro Plc Amended
5th Dec 20222:03 pmRNSForm 8.3 - Devro Plc Amended
5th Dec 20221:40 pmRNSForm 8.3 - Devro Plc
5th Dec 202212:54 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Devro plc
5th Dec 202212:54 pmRNSHolding(s) in Company
5th Dec 202212:51 pmRNSHolding(s) in Company
5th Dec 202211:46 amGNWForm 8.3 - [Devro plc - 02 12 2022] - (CGWL)
5th Dec 202211:24 amRNSForm 8.5 (EPT/NON-RI) - Devro plc
5th Dec 202211:21 amRNSForm 8.3 - Devro PLC
5th Dec 202211:20 amRNSForm 8.5 (EPT/RI) - Devro plc
5th Dec 202211:17 amBUSForm 8.3 - Devro plc
5th Dec 202210:34 amRNSForm 8.5 (EPT/RI) - Devro PLC
5th Dec 202210:03 amRNSForm 8.3 - Devro plc
5th Dec 20227:00 amBUSForm 8.3 - Devro plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.